Acquired 0 8 0 8 B-clinical_variable
immune 9 15 9 15 I-clinical_variable
deficiency 16 26 16 26 I-clinical_variable
syndrome 27 35 27 35 I-clinical_variable
( 36 37 36 37 I-clinical_variable
AIDS 37 41 37 41 I-clinical_variable
) 41 42 41 42 I-clinical_variable
based 43 48 43 48 O
upon 49 53 49 53 O
current 54 61 54 61 O
Centers 62 69 62 69 O
for 70 73 70 73 O
Disease 74 81 74 81 O
and 82 85 82 85 O
Control 86 93 86 93 O
( 94 95 94 95 O
CDC 95 98 95 98 O
) 98 99 98 99 O

Acute 0 5 100 105 O
bacterial 6 15 106 115 B-chronic_disease
or 16 18 116 118 O
fungal 19 25 119 125 B-chronic_disease
infection 26 35 126 135 I-chronic_disease
requiring 36 45 136 145 O
intravenous 46 57 146 157 B-treatment
antibiotics 58 69 158 169 I-treatment
at 70 72 170 172 O
the 73 76 173 176 O
time 77 81 177 181 O
of 82 84 182 184 O
registration 85 97 185 197 O

Bone 0 4 198 202 B-treatment
scan 5 9 203 207 I-treatment
completed 10 19 208 217 O
within 20 26 218 224 O
90 27 29 225 227 B-upper_bound
days 30 34 228 232 I-upper_bound

Chronic 0 7 233 240 B-chronic_disease
obstructive 8 19 241 252 I-chronic_disease
pulmonary 20 29 253 262 I-chronic_disease
disease 30 37 263 270 I-chronic_disease
exacerbation 38 50 271 283 O
or 51 53 284 286 O
other 54 59 287 292 O
respiratory 60 71 293 304 B-chronic_disease
illness 72 79 305 312 I-chronic_disease
requiring 80 89 313 322 O
hospitalization 90 105 323 338 O
or 106 108 339 341 O
precluding 109 119 342 352 O
study 120 125 353 358 B-treatment
therapy 126 133 359 366 I-treatment
at 134 136 367 369 O
the 137 140 370 373 O
time 141 145 374 378 O
of 146 148 379 381 O
registration 149 161 382 394 O

Clinical 0 8 395 403 B-clinical_variable
stage 9 14 404 409 I-clinical_variable
a 15 16 410 411 I-clinical_variable
≤ 17 18 412 413 O
T1 19 21 414 416 B-lower_bound
- 21 22 416 417 O
T2a 22 25 417 420 B-upper_bound
( 26 27 421 422 O
American 27 35 422 430 O
Joint 36 41 431 436 O
Committee 42 51 437 446 O
on 52 54 447 449 O
Cancer 55 61 450 456 O
[ 62 63 457 458 O
AJCC 63 67 458 462 O
] 67 68 462 463 O
7th 69 72 464 467 O
edition 73 80 468 475 O
) 80 81 475 476 O

Eastern 0 7 477 484 B-clinical_variable
Cooperative 8 19 485 496 I-clinical_variable
Oncology 20 28 497 505 I-clinical_variable
Group 29 34 506 511 I-clinical_variable
( 35 36 512 513 I-clinical_variable
ECOG 36 40 513 517 I-clinical_variable
) 40 41 517 518 I-clinical_variable
performance 42 53 519 530 I-clinical_variable
status 54 60 531 537 I-clinical_variable
must 61 65 538 542 O
be 66 68 543 545 O
level 69 74 546 551 O
0 75 76 552 553 B-lower_bound
or 77 79 554 556 O
1 80 81 557 558 B-upper_bound
within 82 88 559 565 O
60 89 91 566 568 B-upper_bound
days 92 96 569 573 I-upper_bound
prior 97 102 574 579 I-upper_bound
to 103 105 580 582 O
registration 106 118 583 595 O

Evidence 0 8 596 604 O
of 9 11 605 607 O
distant 12 19 608 615 B-cancer
metastases 20 30 616 626 I-cancer

Gleason 0 7 627 634 B-clinical_variable
scores 8 14 635 641 I-clinical_variable
≤ 15 16 642 643 O
7(3 17 20 644 647 B-upper_bound
+ 20 21 647 648 I-upper_bound
4 21 22 648 649 I-upper_bound
) 22 23 649 650 I-upper_bound

Hepatic 0 7 651 658 B-chronic_disease
insufficiency 8 21 659 672 I-chronic_disease
resulting 22 31 673 682 O
in 32 34 683 685 O
clinical 35 43 686 694 O
jaundice 44 52 695 703 B-chronic_disease
and/or 53 59 704 710 O
coagulation 60 71 711 722 B-chronic_disease
defects 72 79 723 730 I-chronic_disease
; 79 80 730 731 O
note 81 85 732 736 O
, 85 86 736 737 O
however 87 94 738 745 O
, 94 95 745 746 O
that 96 100 747 751 O
laboratory 101 111 752 762 O
tests 112 117 763 768 O
for 118 121 769 772 O
liver 122 127 773 778 O
function 128 136 779 787 O
and 137 140 788 791 O
coagulation 141 152 792 803 O
parameters 153 163 804 814 O

PSA 0 3 815 818 O
should 4 10 819 825 O
not 11 14 826 829 O
be 15 17 830 832 O
obtained 18 26 833 841 O
prior 27 32 842 847 O
to 33 35 848 850 O
30 36 38 851 853 B-upper_bound
days 39 43 854 858 I-upper_bound
after 44 49 859 864 I-upper_bound
stopping 50 58 865 873 O
finasteride 59 70 874 885 B-treatment

PSA 0 3 886 889 O
should 4 10 890 896 O
not 11 14 897 900 O
be 15 17 901 903 O
obtained 18 26 904 912 O
prior 27 32 913 918 O
to 33 35 919 921 O
90 36 38 922 924 B-upper_bound
days 39 43 925 929 I-upper_bound
after 44 49 930 935 O
stopping 50 58 936 944 O
dutasteride 59 70 945 956 B-treatment

PSA 0 3 957 960 B-clinical_variable
should 4 10 961 967 O
not 11 14 968 971 O
be 15 17 972 974 O
obtained 18 26 975 983 O
within 27 33 984 990 O
10 34 36 991 993 B-upper_bound
days 37 41 994 998 I-upper_bound
after 42 47 999 1004 I-upper_bound
prostate 48 56 1005 1013 B-treatment
biopsy 57 63 1014 1020 I-treatment

Previous 0 8 1021 1029 B-treatment
hormonal 9 17 1030 1038 I-treatment
therapy 18 25 1039 1046 I-treatment
, 25 26 1046 1047 O
such 27 31 1048 1052 O
as 32 34 1053 1055 O
luteinizing 35 46 1056 1067 B-treatment
hormone 47 54 1068 1075 I-treatment
- 54 55 1075 1076 I-treatment
releasing 55 64 1076 1085 I-treatment
hormone 65 72 1086 1093 I-treatment
( 73 74 1094 1095 I-treatment
LHRH 74 78 1095 1099 I-treatment
) 78 79 1099 1100 I-treatment
agonists 80 88 1101 1109 I-treatment
( 89 90 1110 1111 O
e.g. 90 94 1111 1115 O
, 94 95 1115 1116 O
goserelin 96 105 1117 1126 B-treatment
, 105 106 1126 1127 O
leuprolide 107 117 1128 1138 B-treatment
) 117 118 1138 1139 O
or 119 121 1140 1142 O
LHRH 122 126 1143 1147 B-treatment
antagonists 127 138 1148 1159 I-treatment
( 139 140 1160 1161 O
e.g. 140 144 1161 1165 O
, 144 145 1165 1166 O
degarelix 146 155 1167 1176 B-treatment
) 155 156 1176 1177 O
, 156 157 1177 1178 O
anti 158 162 1179 1183 B-treatment
- 162 163 1183 1184 I-treatment
androgens 163 172 1184 1193 I-treatment
( 173 174 1194 1195 O
e.g. 174 178 1195 1199 O
, 178 179 1199 1200 O
flutamide 180 189 1201 1210 B-treatment
, 189 190 1210 1211 O
bicalutamide 191 203 1212 1224 B-treatment
) 203 204 1224 1225 O
, 204 205 1225 1226 O
estrogens 206 215 1227 1236 B-treatment
( 216 217 1237 1238 O
e.g. 217 221 1238 1242 O
, 221 222 1242 1243 O
diethylstilbestrol 223 241 1244 1262 B-treatment
[ 242 243 1263 1264 I-treatment
DES 243 246 1264 1267 I-treatment
] 246 247 1267 1268 I-treatment
) 247 248 1268 1269 O
, 248 249 1269 1270 O
or 250 252 1271 1273 O
surgical 253 261 1274 1282 B-treatment
castration 262 272 1283 1293 I-treatment
( 273 274 1294 1295 I-treatment
orchiectomy 274 285 1295 1306 I-treatment
) 285 286 1306 1307 I-treatment

Previous 0 8 1308 1316 B-treatment
or 9 11 1317 1319 I-treatment
concurrent 12 22 1320 1330 I-treatment
cytotoxic 23 32 1331 1340 I-treatment
chemotherapy 33 45 1341 1353 I-treatment
for 46 49 1354 1357 O
prostate 50 58 1358 1366 B-cancer
cancer 59 65 1367 1373 I-cancer

Previous 0 8 1374 1382 B-treatment
pelvic 9 15 1383 1389 I-treatment
irradiation 16 27 1390 1401 I-treatment
, 27 28 1401 1402 O
prostate 29 37 1403 1411 B-treatment
brachytherapy 38 51 1412 1425 I-treatment
, 51 52 1425 1426 O
or 53 55 1427 1429 O
bilateral 56 65 1430 1439 B-treatment
orchiectomy 66 77 1440 1451 I-treatment

Previous 0 8 1452 1460 B-treatment
radical 9 16 1461 1468 I-treatment
surgery 17 24 1469 1476 I-treatment
( 25 26 1477 1478 O
prostatectomy 26 39 1478 1491 B-treatment
) 39 40 1491 1492 O
, 40 41 1492 1493 O
cryosurgery 42 53 1494 1505 B-treatment
, 53 54 1505 1506 O
or 55 57 1507 1509 O
high 58 62 1510 1514 B-treatment
intensity 63 72 1515 1524 I-treatment
focused 73 80 1525 1532 I-treatment
ultrasound 81 91 1533 1543 I-treatment
( 92 93 1544 1545 I-treatment
HIFU 93 97 1545 1549 I-treatment
) 97 98 1549 1550 I-treatment
for 99 102 1551 1554 O
prostate 103 111 1555 1563 B-cancer
cancer 112 118 1564 1570 I-cancer

Prostate 0 8 1571 1579 B-clinical_variable
specific 9 17 1580 1588 I-clinical_variable
antigen 18 25 1589 1596 I-clinical_variable
( 26 27 1597 1598 I-clinical_variable
PSA 27 30 1598 1601 I-clinical_variable
) 30 31 1601 1602 I-clinical_variable
≤ 32 33 1603 1604 O
10 34 36 1605 1607 B-upper_bound
ng 37 39 1608 1610 I-upper_bound
/ 39 40 1610 1611 I-upper_bound
mL 40 42 1611 1613 I-upper_bound
within 43 49 1614 1620 O
90 50 52 1621 1623 B-upper_bound
days 53 57 1624 1628 I-upper_bound
prior 58 63 1629 1634 I-upper_bound
to 64 66 1635 1637 O
registration 67 79 1638 1650 O

Regional 0 8 1651 1659 B-cancer
lymph 9 14 1660 1665 I-cancer
node 15 19 1666 1670 I-cancer
involvement 20 31 1671 1682 O

Serum 0 5 1683 1688 B-clinical_variable
creatinine 6 16 1689 1699 I-clinical_variable
≤ 17 18 1700 1701 O
1.5 19 22 1702 1705 B-upper_bound
times 23 28 1706 1711 I-upper_bound
upper 29 34 1712 1717 I-upper_bound
limit 35 40 1718 1723 I-upper_bound
of 41 43 1724 1726 I-upper_bound
institutional 44 57 1727 1740 I-upper_bound
normal 58 64 1741 1747 I-upper_bound
( 65 66 1748 1749 O
normal 66 72 1749 1755 O
: 72 73 1755 1756 O
≤ 74 75 1757 1758 O
1.17 76 80 1759 1763 B-upper_bound
mL 81 83 1764 1766 I-upper_bound
/ 83 84 1766 1767 I-upper_bound
min/1.73 84 92 1767 1775 I-upper_bound
m^2 93 96 1776 1779 I-upper_bound
) 96 97 1779 1780 O

Transmural 0 10 1781 1791 B-chronic_disease
myocardial 11 21 1792 1802 I-chronic_disease
infarction 22 32 1803 1813 I-chronic_disease
within 33 39 1814 1820 O
the 40 43 1821 1824 O
last 44 48 1825 1829 B-upper_bound
6 49 50 1830 1831 I-upper_bound
months 51 57 1832 1838 I-upper_bound

Unstable 0 8 1839 1847 B-chronic_disease
angina 9 15 1848 1854 I-chronic_disease
and/or 16 22 1855 1861 O
congestive 23 33 1862 1872 B-chronic_disease
heart 34 39 1873 1878 I-chronic_disease
failure 40 47 1879 1886 I-chronic_disease
requiring 48 57 1887 1896 O
hospitalization 58 73 1897 1912 B-treatment
within 74 80 1913 1919 O
the 81 84 1920 1923 O
last 85 89 1924 1928 B-upper_bound
6 90 91 1929 1930 I-upper_bound
months 92 98 1931 1937 I-upper_bound

Use 0 3 1938 1941 O
of 4 6 1942 1944 O
dutasteride 7 18 1945 1956 B-treatment
within 19 25 1957 1963 O
90 26 28 1964 1966 B-upper_bound
days 29 33 1967 1971 I-upper_bound
prior 34 39 1972 1977 I-upper_bound
to 40 42 1978 1980 O
registration 43 55 1981 1993 O

Use 0 3 1994 1997 O
of 4 6 1998 2000 O
finasteride 7 18 2001 2012 B-treatment
within 19 25 2013 2019 O
30 26 28 2020 2022 B-upper_bound
days 29 33 2023 2027 I-upper_bound
prior 34 39 2028 2033 I-upper_bound
to 40 42 2034 2036 O
registration 43 55 2037 2049 O

be 0 2 2050 2052 O
able 3 7 2053 2057 O
to 8 10 2058 2060 O
undergo 11 18 2061 2068 O
an 19 21 2069 2071 O
MRI 22 25 2072 2075 B-treatment
with 26 30 2076 2080 O
contrast 31 39 2081 2089 O

have 0 4 2090 2094 O
a 5 6 2095 2096 O
histological 7 19 2097 2109 O
evaluation 20 30 2110 2120 O
of 31 33 2121 2123 O
the 34 37 2124 2127 O
prostate 38 46 2128 2136 B-treatment
biopsy 47 53 2137 2143 I-treatment
with 54 58 2144 2148 O
assignment 59 69 2149 2159 O
of 70 72 2160 2162 O
a 73 74 2163 2164 O
Gleason 75 82 2165 2172 B-clinical_variable
score 83 88 2173 2178 I-clinical_variable
to 89 91 2179 2181 O
the 92 95 2182 2185 O
biopsy 96 102 2186 2192 O
material 103 111 2193 2201 O

have 0 4 2202 2206 O
a 5 6 2207 2208 O
histologically 7 21 2209 2223 O
confirmed 22 31 2224 2233 O
diagnosis 32 41 2234 2243 O
of 42 44 2244 2246 O
adenocarcinoma 45 59 2247 2261 B-cancer
of 60 62 2262 2264 I-cancer
the 63 66 2265 2268 I-cancer
prostate 67 75 2269 2277 I-cancer

have 0 4 2278 2282 O
a 5 6 2283 2284 O
history 7 14 2285 2292 O
/ 14 15 2292 2293 O
physical 15 23 2293 2301 O
examination 24 35 2302 2313 O
with 36 40 2314 2318 O
digital 41 48 2319 2326 B-treatment
rectal 49 55 2327 2333 I-treatment
examination 56 67 2334 2345 I-treatment
of 68 70 2346 2348 I-treatment
the 71 74 2349 2352 I-treatment
prostate 75 83 2353 2361 I-treatment
within 84 90 2362 2368 O
90 91 93 2369 2371 B-upper_bound
days 94 98 2372 2376 I-upper_bound
prior 99 104 2377 2382 I-upper_bound
to 105 107 2383 2385 O
screening 108 117 2386 2395 O

human 0 5 2396 2401 B-chronic_disease
immunodeficiency 6 22 2402 2418 I-chronic_disease
virus 23 28 2419 2424 I-chronic_disease
( 29 30 2425 2426 I-chronic_disease
HIV 30 33 2426 2429 I-chronic_disease
) 33 34 2429 2430 I-chronic_disease
testing 35 42 2431 2438 O

unable 0 6 2439 2445 O
to 7 9 2446 2448 O
undergo 10 17 2449 2456 O
an 18 20 2457 2459 O
MRI 21 24 2460 2463 B-treatment
with 25 29 2464 2468 O
contrast 30 38 2469 2477 O

willing 0 7 2478 2485 O
and 8 11 2486 2489 O
able 12 16 2490 2494 O
to 17 19 2495 2497 O
complete 20 28 2498 2506 O
the 29 32 2507 2510 O
Expanded 33 41 2511 2519 O
Prostate 42 50 2520 2528 O
Cancer 51 57 2529 2535 O
Index 58 63 2536 2541 O
Composite 64 73 2542 2551 O
( 74 75 2552 2553 O
EPIC 75 79 2553 2557 O
) 79 80 2557 2558 O
questionnaire 81 94 2559 2572 O
( 95 96 2573 2574 O
baseline 96 104 2574 2582 O
, 104 105 2582 2583 O
6 106 107 2584 2585 B-lower_bound
, 107 108 2585 2586 O
12 109 111 2587 2589 O
and 112 115 2590 2593 O
24 116 118 2594 2596 B-upper_bound
months 119 125 2597 2603 I-upper_bound
post 126 130 2604 2608 O
end 131 134 2609 2612 O
of 135 137 2613 2615 O
radiation 138 147 2616 2625 B-treatment
therapy 148 155 2626 2633 I-treatment
) 155 156 2633 2634 O

